Eighteenth meeting of the WHO Vector Control Advisory Group, 24-26 April 2023 PDF Download

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240077308
Category : Medical
Languages : en
Pages : 28

View

Book Description

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240096671
Category : Medical
Languages : en
Pages : 30

View

Book Description
On 4, 5 and 7 March 2024, the WHO Malaria Policy Advisory Group (MPAG) convened in Yaoundé, Cameroon, to review updates and progress, and to provide guidance on thematic areas of work by the Global Malaria Programme. The meeting focused on the following topics: malaria vaccine introduction and scale-up, and the Gavi-supported malaria learning agenda; the High burden to high impact (HBHI) approach; subnational tailoring; biological threats to vector control in Africa; the strategy to respond to antimalarial drug resistance in Africa; the development of guidelines recommendations on tafenoquine, primaquine and near-patient glucose-6-phosphate dehydrogenase (G6PD) diagnostic tests to support radical cure of Plasmodium vivax; and malaria elimination, including zoonotic malaria.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240066020
Category : Medical
Languages : en
Pages : 38

View

Book Description
Experts from the WHO Vector Control Advisory Group (VCAG) met in a hybrid meeting with product developers, innovators and researchers from 3 to 6 October 2022 for the 17th VCAG meeting. This report details the proceedings and outcomes of the meeting, including advice provided to applicants working on interventions in the following intervention types: sterile males, population suppression induced by gene drive, insecticide treated nets, endectocides and spatial repellents.

Author: Wei-Shu Hu
Publisher: Springer
ISBN: 3540340076
Category : Science
Languages : en
Pages : 179

View

Book Description
Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240078657
Category : Medical
Languages : en
Pages : 62

View

Book Description

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240067299
Category : Medical
Languages : en
Pages : 82

View

Book Description
The Global report on neglected tropical diseases 2023 provides a consolidated, up-to-date assessment of progress towards control, elimination and eradication of 20 diseases and disease groups (NTDs) globally, regionally and nationally. Progress is reported in the context of global commitments, strategies and targets set in the NTD road map 2021-2030. The document covers the first two years of implementation of the road map (2021 and 2022). The information presented is based primarily on epidemiological and programmatic data for interventions conducted in 2021 and gathered in 2022, but the report also describes a wide range of activities and accomplishments that were registered in both 2021 and 2022; comparisons are often made against 2020 and 2019 data, especially with regard to COVID-19 disruptions. It has four sections: Section 1 is an introduction. Section 2 presents the status of the global NTD response. Section 3 charts progress and developments against the three road map pillars. Section 4 sets out priority actions for 2023 and beyond to sustain implementation of the road map and its companion documents. Five annexes to the report provide information for 2021–2022 on regional progress (Annex 1), Weekly Epidemiology Record articles on NTDs (Annex 2), progress and challenges by disease (Annex 3), diagnostic target product profiles (Annex 4) and the status of commitments for donated medicines and health products (Annex 5).

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241580410
Category : Medical
Languages : en
Pages : 82

View

Book Description
In response to the call of the 48th World Health Assembly for a substantial revision of the International Health Regulations, this new edition of the Regulations will enter into force on June 15, 2007. The purpose and scope of the Regulations are "to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade." The Regulations also cover certificates applicable to international travel and transport, and requirements for international ports, airports and ground crossings.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241564997
Category : Medical
Languages : en
Pages : 35

View

Book Description
The World Health Organization's Global Technical Strategy for Malaria 2016- 2030 has been developed with the aim to help countries to reduce the human suffering caused by the world's deadliest mosquito-borne disease. Adopted by the World Health Assembly in May 2015 it provides comprehensive technical guidance to countries and development partners for the next 15 years emphasizing the importance of scaling up malaria responses and moving towards elimination. It also highlights the urgent need to increase investments across all interventions - including preventive measures diagnostic testing treatment and disease surveillance- as well as in harnessing innovation and expanding research. By adopting this strategy WHO Member States have endorsed the bold vision of a world free of malaria and set the ambitious new target of reducing the global malaria burden by 90% by 2030. They also agreed to strengthen health systems address emerging multi-drug and insecticide resistance and intensify national cross-border and regional efforts to scale up malaria responses to protect everyone at risk.

Author: Edward Geehr
Publisher: Simon and Schuster
ISBN: 164821097X
Category : Medical
Languages : en
Pages : 224

View

Book Description
An in-depth guide for parents as they struggle to make informed decisions about vaccines for their children. In Unavoidably Unsafe, Dr. Edward Geehr and Dr. Jeffrey Barke confront the prevailing beliefs surrounding childhood vaccines with unflinching scrutiny and bold insight. As seasoned physicians, they acknowledge the revered status vaccines hold in modern medicine while bravely questioning their safety and efficacy. From the historical triumphs of polio eradication to the complexities of modern immunization schedules, Geehr and Barke unravel the layers of vaccine development and regulation. They shed light on the unintended consequences of vaccine mandates and the erosion of informed consent in the face of mounting pharmaceutical influence. Drawing on decades of clinical experience and exhaustive research, the authors challenge conventional wisdom by addressing critical issues such as: The proliferation of childhood vaccines and their impact on public health The National Childhood Vaccine Injury Act and its implications for vaccine safety The symbiotic relationship between pharmaceutical companies and regulatory agencies The shortcomings of Emergency Use Authorization and its implications for vaccine safety The presence of potentially harmful additives in vaccine formulations A fresh look at possible links between vaccines and autism Cautionary considerations regarding mRNA vaccines and their suitability for children Practical guidance for evaluating the risks and benefits of vaccines for individual children The significance of proper informed consent and patient advocacy in vaccination decisions Unavoidably Unsafe is not an indictment of vaccines but a call to arms for informed decision-making and transparency in healthcare. Geehr and Barke aim to empower parents, guardians, and healthcare providers with the knowledge needed to navigate the complex landscape of childhood immunization responsibly. In a rapidly evolving medical landscape where uncertainties abound, Unavoidably Unsafe serves as a beacon of clarity and integrity, reaffirming the importance of critical thinking and patient-centered care in safeguarding the health and well-being of future generations.

Author:
Publisher:
ISBN: 9783805548182
Category : Human monkeypox
Languages : en
Pages : 140

View

Book Description